Press-release for stocks

Prices are updated after-hours

report crawled time : 12:20

save search

Intchains Group Limited to Report Unaudited Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
Published: 2024-02-18 (Crawled : 12:20) - globenewswire.com
ICG | $8.1 -0.61% 770

n/a

| Email alert Add to watchlist
report year group financial results

ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids
Published: 2024-01-14 (Crawled : 12:20) - arcutis.com
ARQT A | $10.25 1.49% 1.27% 2.5M

Health Technology

| Email alert Add to watchlist
zoryve dermatitis response

Completion of the Third Tranche of Stellantis Share Buyback Program and Weekly Report (December 1-7, 2023)
Published: 2023-12-09 (Crawled : 12:20) - globenewswire.com
STLA | News | $25.79 -0.04% -0.19% 3.3M

Manufacturing

| Email alert Add to watchlist
report

Talent Acquisition Solutions Market Share Research Report [2023-2030] | 102 Pages – Benzinga
Published: 2023-09-17 (Crawled : 12:20) - spacfeed.com
VHAQ | $10.81 0.0% 990

| Email alert Add to watchlist
report acquisition research solutions market

BOS Reports Financial Results for the Second Quarter of the Year 2023
Published: 2023-08-22 (Crawled : 12:20) - globenewswire.com
BOSC | $2.82 0.53% -1.8% 23K

Electronic Technology

| -20.76% | O: 3.67% H: 0.0% C: -1.09%
year financial results

Impact of Ardmore’s Energy Transition Plan highlighted in Sustainability Report
Published: 2023-08-22 (Crawled : 12:20) - ardmoreshipping.com
ASC | $15.86 -0.31% 0.0% 380K

Transportation

| 17.68% | O: 0.3% H: 0.66% C: -1.92%
energy report impact

ToughBuilt Industries to Report Second Quarter 2023 Financial Results on August 22, 2023
Published: 2023-08-17 (Crawled : 12:20) - globenewswire.com
TBLT | $2.4 11.11% 10.74% 720K

Consumer Non-Durables

| -86.22% | O: 2.61% H: 1.74% C: -2.58%
report financial results

Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
Published: 2023-08-17 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.1649 -7.52% -8.92% 130M

Health Technology

| -70.2% | O: -4.06% H: 0.41% C: -2.97%
diarrhea health cancer treatment family crofelemer trial

Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
QLGN | $0.2974 -0.8% -3.02% 48K

Health Technology

| -71.43% | O: -1.9% H: 6.8% C: 6.14%
update financial results

Ascendis Pharma to Report Second Quarter 2023 Financial Results and Provide Business Update on September 5, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
ASND | $142.17 0.47% 0.44% 300K

Health Technology

| 55.54% | O: 1.68% H: 2.74% C: 0.0%
pharma report business update financial results

SoundThinking, Inc. Releases Second ESG Report: Addressing and Enabling Equitable Outcomes for Public Safety and Social Good
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
SSTI | $13.31 -2.2% -2.1% 40K

Electronic Technology

| -33.12% | O: 9.7% H: 3.32% C: 0.96%
enabling esg

Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CLRB | $3.21 -3.02% -3.44% 850K

Health Technology

| 106.88% | O: -1.88% H: 6.37% C: 3.82%
update financial results

BTCS Reports Q2 2023 Results
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CRCW | News | $0.0016 -5.88% 27.78% 7.8M

Information

| 13.33% | O: 0.0% H: 0.0% C: -1.0%
BTCS | $1.39 -0.71% -0.72% 80K

Manufacturing

| 33.33% | O: 0.0% H: 1.87% C: 0.95%
results

Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ELOX | $0.9625 -2.52% -51.57% 93K

Health Technology

| -79.21% | O: 5.05% H: 20.04% C: 14.83%
business update pharmaceuticals financial results

Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
NMRD | $0.1053 -17.8% -28.78% 29K

Health Technology

| -89.74% | O: 19.29% H: 4.23% C: -14.37%
business update medical results

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CFRX | $0.05 0.0% 910K

Health Technology

| -94.76% | O: 4.71% H: 0.0% C: -4.01%
business update financial results

ARRIVAL to Report Second Quarter 2023 Business Updates in Early September 2023
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -73.17% | O: -4.88% H: 1.03% C: -2.05%
report business

Integra Files Maiden Preliminary Economic Assessment Technical Report for Wildcat & Mountain View Projects
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ITRG | $0.8807 -0.15% 0.0% 240K

Non-Energy Minerals

| 1.7% | O: 1.7% H: 1.14% C: -3.63%
report

CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Reiterates Upcoming Milestones
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
CNSP A | $0.2044 -1.97% -1.02% 210K

Health Technology

| -89.73% | O: -2.46% H: 2.53% C: -10.61%
pharmaceuticals financial results

Cybin Reports First Quarter Financial Results and Recent Business Highlights
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
CYBN | $0.3754 -1.11% -2.58% 2M

n/a